February 14, 2022 10:49 AM EST
R&D
News Briefing

Bavar­i­an Nordic lands break­through des­ig­na­tion for RSV vac­cine; Ucel­lo clos­es Se­ries A to ad­vance CAR-T ther­a­pies

Josh Sullivan

The FDA has grant­ed Bavar­i­an Nordic a Break­through Ther­a­py Des­ig­na­tion for its vac­cine to pre­vent low­er res­pi­ra­to­ry tract dis­ease caused by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

Mod­er­na CEO de­fends pan­dem­ic prep ef­forts with crit­ics set to en­ter Trump’s ad­min­is­tra­tion

Trade group tells FDA that semaglu­tide is not too 'com­plex' for com­pound­ing

A service from the Financial Times